Hamamatsu Photonics has reported net sales up by 7.7 per cent at the close of its 2015 fiscal year, while Newport and Rofin both post static net sales.
Newport grew 0.9 per cent for its third quarter 2015 compared to the same period last year. Rofin’s net sales were down 2 per cent at the end of its 2015 fiscal year, despite quarterly fibre laser sales increasing by almost 80 per cent year-on-year.
Hamamatsu’s net sales for 2015 were JPY 120,691 million ($983 million), up by JPY 8,598 million ($70 million). Its opto-semiconductor segment grew by 5.7 per cent to JPY 51,944 million ($423 million), thanks to sales of silicon photodiodes in medical devices in North America, and demand for photo ICs for the automotive industry in Europe.
The company’s imaging and measurement systems business is particularly healthy, growing 15.5 per cent to JPY 16,201 million ($132 million) thanks to sales of digital cameras, as well as X-ray line sensor cameras for food inspection. Its electron tube sector grew by 6.9 per cent to JPY 48,706 million ($397 million).
However, the company is cautious about its financial predictions for next year, citing struggling economies in Europe and an economic slowdown in newly developing countries as both areas of uncertainty for the near future. Hamamatsu expects consolidated net sales for 2016 of JPY 126,900 million ($1,033 million), up by 5.1 per cent.
Rofin’s net sales totalled $519.6 million, a decrease of $10.5 million or 2 per cent compared to the previous fiscal year. Net sales of lasers for macro applications decreased by 4 per cent, while sales of components increased 8 per cent. The company expects revenues to grow to $525 million to $545 million in the 2016 fiscal year.
Newport posted net sales of $147.6 million for its third quarter 2015, with scientific research and defence segments particularly strong, both growing around 13 per cent. The microelectronics and life sciences segments both decreased by around 6 per cent, while the industrial manufacturing segment dropped by 2 per cent.
Further information: